https://www.mmm-online.com/pages/rss.aspx?sectionid=61 Latest articles from Medical Marketing and Media Channel Channel Channel mmmsubs@haymarketmedia.com no Christopher Boerner was promoted to lead commercial at BMS, and Laura Hamill joined Gilead from Amgen to head up its commercial operations. https://www.mmm-online.com/changes-at-the-top-of-commercial-units-for-gilead-and-bms/article/791998/ Wed, 29 Aug 2018 15:00:45 GMT Christopher Boerner was promoted to lead commercial at BMS, and Laura Hamill joined Gilead from Amgen to head up its commercial operations. https://www.mmm-online.com/changes-at-the-top-of-commercial-units-for-gilead-and-bms/article/791998/ Gilead appoints new commercial lead; U.K. bans online ad for contraception app; Pfizer petitions the FDA to clarify biosimilar communications. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-wednesday-august-29-2018/article/791985/ Wed, 29 Aug 2018 14:10:01 GMT Gilead appoints new commercial lead; U.K. bans online ad for contraception app; Pfizer petitions the FDA to clarify biosimilar communications. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-wednesday-august-29-2018/article/791985/ Some of the advertising industry's top analysts say Mark Read looks the best choice to be WPP's chief executive and the board would need to find a "spectacular" alternative. https://www.mmm-online.com/if-wpps-next-ceo-isnt-mark-read-its-got-to-be-a-spectacular-choice-analysts-say/article/791869/ Wed, 29 Aug 2018 11:00:00 GMT Some of the advertising industry's top analysts say Mark Read looks the best choice to be WPP's chief executive and the board would need to find a "spectacular" alternative. https://www.mmm-online.com/if-wpps-next-ceo-isnt-mark-read-its-got-to-be-a-spectacular-choice-analysts-say/article/791869/ Amarin's Vascepa trial is set to read out results by the end of September. https://www.mmm-online.com/after-failure-of-generic-fish-oil-trial-some-caution-against-read-across-to-vascepa-study/article/791882/ Wed, 29 Aug 2018 11:00:00 GMT Amarin's Vascepa trial is set to read out results by the end of September. https://www.mmm-online.com/after-failure-of-generic-fish-oil-trial-some-caution-against-read-across-to-vascepa-study/article/791882/ Gilead's CAR-T cell therapy ruled too expensive in the U.K.; Experts mixed on impact of drug price hike freezes; Women turn to wearables for fertility tracking https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-tuesday-august-28-2018/article/791648/ Tue, 28 Aug 2018 14:21:24 GMT Gilead's CAR-T cell therapy ruled too expensive in the U.K.; Experts mixed on impact of drug price hike freezes; Women turn to wearables for fertility tracking https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-tuesday-august-28-2018/article/791648/ Some of the world's most powerful pharmaceutical companies backed down on planned price increases following a new transparency law in California and social media hectoring from President Donald Trump. https://www.mmm-online.com/experts-split-on-impact-of-drug-price-hike-freezes/article/791537/ Tue, 28 Aug 2018 11:00:00 GMT Some of the world's most powerful pharmaceutical companies backed down on planned price increases following a new transparency law in California and social media hectoring from President Donald Trump. https://www.mmm-online.com/experts-split-on-impact-of-drug-price-hike-freezes/article/791537/ Pfizer's drug tafamidis reduces risk of death; Lilly Diabetes pulls its sponsorship of Daly's car; FDA investigates electronic cigarette maker Juul. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-monday-august-27-2018/article/791336/ Mon, 27 Aug 2018 14:13:16 GMT Pfizer's drug tafamidis reduces risk of death; Lilly Diabetes pulls its sponsorship of Daly's car; FDA investigates electronic cigarette maker Juul. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-monday-august-27-2018/article/791336/ Chase Design Group's John Tanner shares what he thinks brands can do to spice things up when it comes to marketing around marijuana. https://www.mmm-online.com/the-highs-and-lows-of-cannabis-branding/article/791334/ Mon, 27 Aug 2018 13:51:05 GMT Chase Design Group's John Tanner shares what he thinks brands can do to spice things up when it comes to marketing around marijuana. https://www.mmm-online.com/the-highs-and-lows-of-cannabis-branding/article/791334/ As more medications are approved, pharma companies are being pushed farther afield into a land of bizarre — but hopefully still memorable and vaguely meaningful — drug names. https://www.mmm-online.com/a-peek-into-the-sometimes-bizarre-land-of-pharma-brand-naming/article/790160/ Mon, 27 Aug 2018 11:00:00 GMT As more medications are approved, pharma companies are being pushed farther afield into a land of bizarre — but hopefully still memorable and vaguely meaningful — drug names. https://www.mmm-online.com/a-peek-into-the-sometimes-bizarre-land-of-pharma-brand-naming/article/790160/ White House proposes rule for drug prices in DTC ads; FDA to study impact of side-effects warnings in drug ads; FDA approves Shire's potential blockbuster HAE treatment. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-friday-august-24-2018/article/790985/ Fri, 24 Aug 2018 14:19:09 GMT White House proposes rule for drug prices in DTC ads; FDA to study impact of side-effects warnings in drug ads; FDA approves Shire's potential blockbuster HAE treatment. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-friday-august-24-2018/article/790985/ The companies plan to make the most of favorable market access conditions for the at-home colon cancer screening test. https://www.mmm-online.com/behind-the-exact-sciences-pfizer-cologuard-co-promotion-deal/article/790982/ Fri, 24 Aug 2018 13:51:22 GMT The companies plan to make the most of favorable market access conditions for the at-home colon cancer screening test. https://www.mmm-online.com/behind-the-exact-sciences-pfizer-cologuard-co-promotion-deal/article/790982/ Biosimilars have only been in the market for three years, but they have struggled to compete with their branded equivalents. https://www.mmm-online.com/pfizer-lawsuit-could-clear-path-for-biosimilars/article/790686/ Thu, 23 Aug 2018 17:00:00 GMT Biosimilars have only been in the market for three years, but they have struggled to compete with their branded equivalents. https://www.mmm-online.com/pfizer-lawsuit-could-clear-path-for-biosimilars/article/790686/ https://www.mmm-online.com/read-the-august-2018-digital-ediiton/article/790685/ Thu, 23 Aug 2018 14:49:10 GMT https://www.mmm-online.com/read-the-august-2018-digital-ediiton/article/790685/ Trump's conflicting policies on PBMs confuse the industry; Pfizer strikes deal to co-promote Cologuard; Tech company develops microchip for dementia patients. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-thursday-august-23-2018/article/790668/ Thu, 23 Aug 2018 13:50:41 GMT Trump's conflicting policies on PBMs confuse the industry; Pfizer strikes deal to co-promote Cologuard; Tech company develops microchip for dementia patients. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-thursday-august-23-2018/article/790668/ FDA extends EpiPen expiration dates; GE Ventures senior managing director departs; Facebook launches MRI research project. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-wednesday-august-21-2018/article/790311/ Wed, 22 Aug 2018 14:16:13 GMT FDA extends EpiPen expiration dates; GE Ventures senior managing director departs; Facebook launches MRI research project. https://www.mmm-online.com/five-things-for-pharma-marketers-to-know-wednesday-august-21-2018/article/790311/